MedTrace Logo

Steno Tech Explore: A Study of Insulin Pump Users With Type 1 Diabetes

NCT04311164 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 770

Last updated 2021-02-01

No results posted yet for this study

Summary

The present study is part of an overarching study being conducted in Denmark at Steno Diabetes Center Copenhagen (SDCC) and Nordsjællands Hospital Hillerød (NOH), Steno Tech, that aims to develop and ultimately, in a randomized controlled trial (RCT), test approaches that can assist people with type 1 diabetes in obtaining optimal outcomes using CSII. Through a large-scale, questionnaire-based online survey enriched with data from national registers, this sub-study contributes to this overarching aim by exploring the importance of individual differences across a wide range of factors, including demographic, socioeconomic, health status, psychosocial and preference structures, for optimal use of CSII in people with type 1 diabetes.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

OTHER

Questionnaire-based survey

The online questionnaire-based survey is composed of multiple items including pre-coded (multiple choice) questions, dichotomous (yes/no) questions, rating scales and validated questionnaire scales to measure general and diabetes/insulin pump-specific behavior, psychological concepts and preferences.

OTHER

No intervention given.

No intervention was given.

Sponsors & Collaborators

  • Nordsjaellands Hospital

    collaborator OTHER

  • Steno Diabetes Center Copenhagen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-15
Primary Completion
2020-10-15
Completion
2020-10-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04311164 on ClinicalTrials.gov